Difference between revisions of "Team:AFCM-Egypt"
Aymanshafei (Talk | contribs) |
Ahmedashry (Talk | contribs) |
||
| Line 116: | Line 116: | ||
<div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"> | <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"> | ||
<ul id="menu"> | <ul id="menu"> | ||
| − | <li class="active"><a href=" | + | <li class="active"><a href="https://2017.igem.org/Team:AFCM-Egypt">HOME</a> </li> |
<li> | <li> | ||
<a>TEAM <span class="caret"></span></a> | <a>TEAM <span class="caret"></span></a> | ||
<ul> | <ul> | ||
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Meet_the_team.html">Meet The Team</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Collaborations.html">Collaborations</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 127: | Line 127: | ||
<a>PROJECT <span class="caret"></span></a> | <a>PROJECT <span class="caret"></span></a> | ||
<ul> | <ul> | ||
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Project.html">Project Descreption</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Experiment.html">Experiment</a></li> |
| − | <li><a href="Result.html">Result</a></li> | + | <li><a href="https://2017.igem.org/Result.html">Result</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Proof_of_concept.html">Proof of concept</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 137: | Line 137: | ||
<ul> | <ul> | ||
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Parts.html">Parts</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Basic_parts.html">Basic Parts</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Compopsite_parts.html">Composite Parts</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Revision as of 13:30, 21 October 2017
Abstract
Knock-in of Circular RNA gene in Hepatocellular Carcinoma cells via CRISPR/Cas9
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers
in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-.
"Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique
that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma.
This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.
This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials. This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
AFCM-Egypt
We strive to excel
click here
